Literature DB >> 22354751

Dogs with congenital porto-systemic shunting (cPSS) and hepatic encephalopathy have higher serum concentrations of C-reactive protein than asymptomatic dogs with cPSS.

A G Gow1, A I Marques, D A Yool, K Crawford, S M Warman, P D Eckersall, R Jalan, R J Mellanby.   

Abstract

Hepatic encephalopathy (HE) is a cause of significant morbidity and mortality in patients with liver disorders and a wide range of rodent models of HE have been described to facilitate studies into the pathogenesis and treatment of HE. However, it is widely acknowledged that no individual model perfectly mimics human HE and there is a particular need for spontaneous, larger animal models. One common congenital abnormality in dogs is the portosystemic shunt (cPSS) which causes clinical signs that are similar to human HE such as ataxia, disorientation, lethargy and occasionally coma. As inflammation has recently been shown to be associated with HE in humans, we hypothesised that inflammation would similarly be associated with HE in dogs with cPSS. To examine this hypothesis we measured C-reactive protein (CRP) in 30 healthy dogs, 19 dogs with a cPSS and no HE and 27 dogs with a cPSS and overt HE. There was a significant difference in CRP concentration between healthy dogs and dogs with HE (p < 0.001) and between dogs with HE and without HE (p < 0.05). The novel finding that there is an association between inflammation and canine HE strengthens the concept that HE in dogs with cPSS shares a similar pathogenesis to humans with HE. Consequently, dogs with a cPSS may be a good spontaneous model of human HE in which to further examine the role of inflammation and development of HE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22354751     DOI: 10.1007/s11011-012-9278-x

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  15 in total

Review 1.  Experimental models of hepatic encephalopathy: ISHEN guidelines.

Authors:  Roger F Butterworth; Michael D Norenberg; Vicente Felipo; Peter Ferenci; Jan Albrecht; Andres T Blei
Journal:  Liver Int       Date:  2009-07       Impact factor: 5.828

Review 2.  Acute phase proteins: Biomarkers of infection and inflammation in veterinary medicine.

Authors:  P D Eckersall; R Bell
Journal:  Vet J       Date:  2010-06-02       Impact factor: 2.688

3.  Acute phase protein concentrations in dogs with nasal disease.

Authors:  D Sheahan; R Bell; R J Mellanby; A G Gow; E Friend; J Heller; L M Bence; P D Eckersall
Journal:  Vet Rec       Date:  2010-12-04       Impact factor: 2.695

Review 4.  Review article: the burden of hepatic encephalopathy.

Authors:  F F Poordad
Journal:  Aliment Pharmacol Ther       Date:  2007-02       Impact factor: 8.171

5.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

Review 6.  Hepatic encephalopathy: from pathophysiology to treatment.

Authors:  Antoni Mas
Journal:  Digestion       Date:  2006-02-08       Impact factor: 3.216

7.  Measurement of brain trace elements in a dog with a portosystemic shunt: relation between hyperintensity on T1-weighted magnetic resonance images in lentiform nuclei and brain trace elements.

Authors:  Shidow Torisu; Makoto Washizu; Daisuke Hasegawa; Hiromitsu Orima
Journal:  J Vet Med Sci       Date:  2008-12       Impact factor: 1.267

8.  Whole blood manganese concentrations in dogs with congenital portosystemic shunts.

Authors:  A G Gow; A I C Marques; D A Yool; A Duncan; R J Mellanby
Journal:  J Vet Intern Med       Date:  2010 Jan-Feb       Impact factor: 3.333

Review 9.  Important clinical syndromes associated with liver disease.

Authors:  Jan Rothuizen
Journal:  Vet Clin North Am Small Anim Pract       Date:  2009-05       Impact factor: 2.093

Review 10.  Portosystemic vascular anomalies.

Authors:  Allyson C Berent; Karen M Tobias
Journal:  Vet Clin North Am Small Anim Pract       Date:  2009-05       Impact factor: 2.093

View more
  11 in total

1.  Surgical attenuation of spontaneous congenital portosystemic shunts in dogs resolves hepatic encephalopathy but not hypermanganesemia.

Authors:  Adam G Gow; Polly E Frowde; Clive M Elwood; Carolyn A Burton; Roger M Powell; Simon W Tappin; Rob D Foale; Andrew Duncan; Richard J Mellanby
Journal:  Metab Brain Dis       Date:  2015-05-05       Impact factor: 3.584

2.  Hyperammonemia and systemic inflammatory response syndrome predicts presence of hepatic encephalopathy in dogs with congenital portosystemic shunts.

Authors:  Mickey S Tivers; Ian Handel; Adam G Gow; Vicky J Lipscomb; Rajiv Jalan; Richard J Mellanby
Journal:  PLoS One       Date:  2014-01-02       Impact factor: 3.240

3.  Attenuation of congenital portosystemic shunt reduces inflammation in dogs.

Authors:  Michael S Tivers; Ian Handel; Adam G Gow; Victoria J Lipscomb; Rajiv Jalan; Richard J Mellanby
Journal:  PLoS One       Date:  2015-02-06       Impact factor: 3.240

4.  Astrocyte lesions in cerebral cortex and cerebellum of dogs with congenital ortosystemic shunting.

Authors:  Alun Williams; Adam Gow; Scott Kilpatrick; Mickey Tivers; Vicky Lipscomb; Ken Smith; Michael Oliver Day; Nick Jeffery; Richard John Mellanby
Journal:  J Vet Sci       Date:  2020-05       Impact factor: 1.672

5.  Evaluation of serum lidocaine/monoethylglycylxylidide concentration to assess shunt closure in dogs with extrahepatic portosystemic shunts.

Authors:  Nausikaa Devriendt; Gonçalo Serrano; Siska Croubels; Emmelie Stock; Eva Vandermeulen; Dominique Paepe; Jennifer von Luckner; Hilde de Rooster
Journal:  J Vet Intern Med       Date:  2021-01-12       Impact factor: 3.175

Review 6.  Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management.

Authors:  Stefania Gioia; Silvia Nardelli; Oliviero Riggio; Jessica Faccioli; Lorenzo Ridola
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

7.  Comparison of diet, lactulose, and metronidazole combinations in the control of pre-surgical clinical signs in dogs with congenital extrahepatic portosystemic shunts.

Authors:  Goncalo Serrano; Nausikaa Devriendt; Hilde de Rooster; Dominique Paepe
Journal:  J Vet Intern Med       Date:  2022-05-28       Impact factor: 3.175

8.  Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach.

Authors:  Josipa Kuleš; Vladimir Mrljak; Renata Barić Rafaj; Jelena Selanec; Richard Burchmore; Peter D Eckersall
Journal:  BMC Vet Res       Date:  2014-05-12       Impact factor: 2.741

9.  Evaluation of potential serum biomarkers of hepatic fibrosis and necroinflammatory activity in dogs with liver disease.

Authors:  Chantel Raghu; Joanne Ekena; John M Cullen; Craig B Webb; Lauren A Trepanier
Journal:  J Vet Intern Med       Date:  2018-02-27       Impact factor: 3.333

10.  Outcome of non-surgical dietary treatment with or without lactulose in dogs with congenital portosystemic shunts.

Authors:  Robert P Favier; Eline de Graaf; Ronald J Corbee; Anne Kummeling
Journal:  Vet Q       Date:  2020-12       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.